ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

In Brief: USC Study Finds Sedentary Occupations Increase Colon Cancer Risk for Men Over More Active Jobs

November 30, 1984

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

Data-Dredging? Don’t Try It, FDA Says.

May 11, 2007

ASCO 2012: Michael Link’s Presidential Address, and the 2012 Award Winners

June 8, 2012

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011